Shivani D. Rangwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shivani D. Rangwala has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Darren B. Orbach
Neurointerventional Radiology, Boston Children's Hospital Harvard Medical School Boston MA USA
2 shared publications - Frank Attenello
Department of Neurological Surgery, University of Southern California, Los Angeles, CA, USA
2 shared publications - Li Ding
Department of Population and Public Health Sciences, Keck School of Medicine of University of Southern California, Los Angeles, CA; and
2 shared publications - William J. Mack
Department of Neurological Surgery, Keck School of Medicine of USC, University of Southern California, Los Angeles, California, USA
2 shared publications - Alfred Pokmeng See
Department of Neurosurgery, Boston Children’s Hospital, Harvard Medical School, Boston, USA
1 shared publication Carol B Benson
Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in World Neurosurgery
Peritoneal re-internalization of shunts after pseudocyst treatment: a 24-year single institution experience
- 26 October 2026
- Published by Elsevier in World Neurosurgery
Open AccessPeritoneal re-internalization of shunts after pseudocyst treatment: a 24-year single institution experience
- 24 May 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (10) , 1586-1592
Comparing Vascular Morphology and Hemodynamics in Patients with Vein of Galen Malformations Using Intracranial 4D Flow MRI
Vein of Galen malformation (VOGM) is the most common congenital cerebrovascular malformation, and many patients suffer high mortality rates and poor cognitive outcomes. Quantitative diagnostic tools are needed to improve clinical outcomes. A prospective study of children with VOGM was conducted by acquiring 4D flow MRI to quantify total blood inflow to the brain, flow in the pathologic falcine sinus, and flow in the superior sagittal sinus. Linear regression was used to test the relationships between these flows and age, clinical status, and the mediolateral diameter of the lesion's outflow tract through the falcine or straight sinus (MD), which is a known morphological prognostic metric. In all 11 subjects (mean age 22±17 weeks [SD]), total blood flow to the brain always exceeded normal levels (1063±403 ml/min [mean±SD]). Significant correlations were observed between falcine sinus flow and MD, the posterior/middle cerebral artery flow ratio and age at scan, and between superior sagittal sinus flow proximal to malformation inflow and age at scan. Using 4D flow MRI we established the hemodynamic underpinnings of MD, and investigated metrics representing parenchymal venous drainage that could be used to monitor the normalization of hemodynamics during embolization therapy. ACA = anterior cerebral artery; BA = basilar artery; MD = falcine or straight sinus mediolateral diameter; NAR = neonatal at risk; PCA = posterior cerebral artery; PCom = posterior communicating artery; SSS = superior sagittal sinus; VOGM = vein of Galen malformation.
- 24 May 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (10) , 1586-1592
Comparing Vascular Morphology and Hemodynamics in Patients with Vein of Galen Malformations Using Intracranial 4D Flow MRI
Vein of Galen malformation (VOGM) is the most common congenital cerebrovascular malformation, and many patients suffer high mortality rates and poor cognitive outcomes. Quantitative diagnostic tools are needed to improve clinical outcomes. A prospective study of children with VOGM was conducted by acquiring 4D flow MRI to quantify total blood inflow to the brain, flow in the pathologic falcine sinus, and flow in the superior sagittal sinus. Linear regression was used to test the relationships between these flows and age, clinical status, and the mediolateral diameter of the lesion's outflow tract through the falcine or straight sinus (MD), which is a known morphological prognostic metric. In all 11 subjects (mean age 22±17 weeks [SD]), total blood flow to the brain always exceeded normal levels (1063±403 ml/min [mean±SD]). Significant correlations were observed between falcine sinus flow and MD, the posterior/middle cerebral artery flow ratio and age at scan, and between superior sagittal sinus flow proximal to malformation inflow and age at scan. Using 4D flow MRI we established the hemodynamic underpinnings of MD, and investigated metrics representing parenchymal venous drainage that could be used to monitor the normalization of hemodynamics during embolization therapy. ACA = anterior cerebral artery; BA = basilar artery; MD = falcine or straight sinus mediolateral diameter; NAR = neonatal at risk; PCA = posterior cerebral artery; PCom = posterior communicating artery; SSS = superior sagittal sinus; VOGM = vein of Galen malformation.
- 7 November 2023
- Published by Elsevier in World Neurosurgery
- Vol. 181, e882-e896
Frailty is a Predictor of Increased Readmissions and Increased Postoperative Complications After Elective Treatment of Unruptured Aneurysms
- 7 November 2023
- Published by Elsevier in World Neurosurgery
- Vol. 181, e882-e896
Frailty is a Predictor of Increased Readmissions and Increased Postoperative Complications After Elective Treatment of Unruptured Aneurysms
- 3 June 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 1-8
Carotid artery stenting for asymptomatic stenosis is associated with decreased 30-day readmission at very high volume centers
- 3 June 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 1-8
Carotid artery stenting for asymptomatic stenosis is associated with decreased 30-day readmission at very high volume centers
- 23 January 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 15 (12) , 1218-1223
Overcoming roadblocks in clinical innovation via high fidelity simulation: use of a phantom simulator to achieve FDA and IRB approval of a clinical trial of fetal embolization of vein of Galen malformations
Background Vein of Galen malformation (VOGM) is a rare, life-threatening vascular malformation in neonates and is treated with embolization. However, even at the most experienced centers, patients face high mortality and morbidity. In utero treatment options have been limited by lack of animal models or simulations. Objective To create a novel ultrasound phantom simulator for a preclinical feasibility study of in utero fetal intervention for VOGM. Methods Novel phantoms were designed and built in two configurations of spherical and windsock shape from cryogel material to mimic the salient vasculature of the fetal VOGM, based on real-patient fetal MR imaging dimensions. Critical anatomy was realistically mimicked within this model and transtorcular ultrasound-guided coil deployment was simulated. Each phantom model was assessed before and after treatment to evaluate coil mass deposition within the target. Results The two phantoms underwent pretreatment T2-weighted MR imaging assessment, ultrasound-guided embolization, post-treatment MR and fluoroscopic imaging, and visual inspection of the sliced phantoms for target embolization verification. Postoperative MR scans confirmed realistic compact deposition of the coil masses within the central cavity. Phantom embolization results were submitted as part of the institutional review board and US Food and Drug Administration investigative device exemption approval for a first-in-humans clinical trial of fetal intervention for VOGM. Conclusions A phantom simulator for fetal intervention of VOGM produces lifelike results during trial interventions, removing obstacles to feasibility and safety evaluations, typically precluded by non-availability of appropriate animal models. The study provides a proof of concept for potentially wider applications of medical simulation to enable novel procedural advancements in neurointerventions.
- 23 January 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 15 (12) , 1218-1223
Overcoming roadblocks in clinical innovation via high fidelity simulation: use of a phantom simulator to achieve FDA and IRB approval of a clinical trial of fetal embolization of vein of Galen malformations
Background Vein of Galen malformation (VOGM) is a rare, life-threatening vascular malformation in neonates and is treated with embolization. However, even at the most experienced centers, patients face high mortality and morbidity. In utero treatment options have been limited by lack of animal models or simulations. Objective To create a novel ultrasound phantom simulator for a preclinical feasibility study of in utero fetal intervention for VOGM. Methods Novel phantoms were designed and built in two configurations of spherical and windsock shape from cryogel material to mimic the salient vasculature of the fetal VOGM, based on real-patient fetal MR imaging dimensions. Critical anatomy was realistically mimicked within this model and transtorcular ultrasound-guided coil deployment was simulated. Each phantom model was assessed before and after treatment to evaluate coil mass deposition within the target. Results The two phantoms underwent pretreatment T2-weighted MR imaging assessment, ultrasound-guided embolization, post-treatment MR and fluoroscopic imaging, and visual inspection of the sliced phantoms for target embolization verification. Postoperative MR scans confirmed realistic compact deposition of the coil masses within the central cavity. Phantom embolization results were submitted as part of the institutional review board and US Food and Drug Administration investigative device exemption approval for a first-in-humans clinical trial of fetal intervention for VOGM. Conclusions A phantom simulator for fetal intervention of VOGM produces lifelike results during trial interventions, removing obstacles to feasibility and safety evaluations, typically precluded by non-availability of appropriate animal models. The study provides a proof of concept for potentially wider applications of medical simulation to enable novel procedural advancements in neurointerventions.
- 1 January 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 200, 106383
Tobacco Use Is Associated with Readmission within 90 Days after Craniotomy
- 1 January 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 200, 106383
Tobacco Use Is Associated with Readmission within 90 Days after Craniotomy